---
schema_version: "secwatch.filing_event.v1"
accession: "0001826466-24-000020"
form_type: "8-K"
ticker: "NIKA"
cik: "0001145604"
company_name: "NIKA PHARMACEUTICALS, INC"
filed_at: "2024-03-05T23:59:59+00:00"
generated_at: "2026-06-05T03:25:04.559620+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Nika Pharmaceuticals completes merger with Nika BioTechnology; increases preferred authorized shares

## Summary
- Merger effective March 1, 2024; Nika BioTech shareholders receive 1 NKPH share per NIKA share.
- Controlling shareholder Dimitar Slavchev Savov owns ~69% of merged entity's common and 100% of Preferred A.
- Articles amended to increase authorized Preferred A shares from 10M to 15M, filed March 4, 2024.
- Both companies had same board and officers; management unchanged post-merger.
- Shareholders approved the merger on February 12, 2024, and the transaction closed as planned.

## SEC filing metadata
- accession: 0001826466-24-000020
- form_type: 8-K
- ticker: NIKA
- cik: 0001145604
- company_name: NIKA PHARMACEUTICALS, INC
- filed_at: 2024-03-05T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1145604/000182646624000020/0001826466-24-000020-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1145604/000182646624000020/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001826466-24-000020
- JSON: https://secwatch.observer/filing/0001826466-24-000020.json
- Plain text: https://secwatch.observer/filing/0001826466-24-000020.txt

## Key facts
- Governance Changes
  NIKA PHARMACEUTICALS, INC: Increased authorized Preferred A stock from 10,000,000 to 15,000,000 (effective 2024-03-04).
  - Change: charter amendment
  - Effective: 2024-03-04
  source text: Pursuant to the terms of the Agreement and Plan of Merger and the approval of the company’s board of directors and shareholders, Nika Pharmaceuticals, Inc. has filed an Amendment to the Articles of Incorporation to increase the number of authorized Preferred A stock from 10,000,000 to 15,000,000, effective as of March 4, 2024 when the amendment was filed with the Colorado Secretary of State.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1145604/000182646624000020/0001826466-24-000020-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.